Professor Langley has an international reputation in the area of prostate cancer.
He was first to describe the technique of a transperineal template biopsy of the prostate in 2004, a new improved way to examine the prostate, which minimises infection and increases the accuracy of detection.
He also has been a pioneer of prostate Brachytherapy, a minimally invasive technique to treat prostate cancer using tiny radioactive seeds implanted into the prostate under a light anaesthetic. He has treated over 3,500 patients and for low and intermediate risk prostate cancer his cure rates exceed 90% with less than 1% incontinence and over 80% potent. He also undertakes robotic radical prostatectomy for men more suited to radical surgery.
He has a wide practice specialising in all the areas of prostate diseases using the latest techniques including multi-parametric MRI for biopsy targeting and PMSA PET:CT scans for staging advanced cancers.